Gene · 2877
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The gut peptide Reg3g links the small intestine microbiome to the regulation of energy balance, glucose levels, and gut function. | Cell Metab | 2022 | 36240758 | PubTator, text mining | PubMed |
| Antioxidant Effects of Bioactive Glasses (BGs) and Their Significance in Tissue Engineering Strategies. | Molecules | 2022 | 36235178 | PubTator, text mining | PubMed |
| Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies. | Cancers (Basel) | 2022 | 36230714 | PubTator, text mining | PubMed |
| Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‑mutated lung cancer cells. | Oncol Rep | 2022 | 36222298 | PubTator, text mining | PubMed |
| Atrazine-induced oxidative damage via modulating xenobiotic-sensing nuclear receptors and cytochrome P450 systems in cerebrum and antagonism of lycopene. | Food Chem Toxicol | 2022 | 36216167 | PubTator, text mining | PubMed |
| Editorial: The role of iron in cancer progression. | Front Oncol | 2022 | 36212412 | PubTator, text mining | PubMed |
| Crosstalk between regulated necrosis and micronutrition, bridged by reactive oxygen species. | Front Nutr | 2022 | 36211509 | PubTator, text mining | PubMed |
| Inflammatory effects of hexavalent chromium in the lung: A comprehensive review. | Toxicol Appl Pharmacol | 2022 | 36208701 | PubTator, text mining | PubMed |
| Epigallocatechin-3-gallate suppresses hemin-aggravated colon carcinogenesis through Nrf2-inhibited mitochondrial reactive oxygen species accumulation. | J Vet Sci | 2022 | 36174978 | PubTator, text mining | PubMed |
| Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis. | Sci Rep | 2022 | 36167975 | PubTator, text mining | PubMed |
| Does Methionine Status Influence the Outcome of Selenomethinione Supplementation? A Comparative Study of Metabolic and Selenium Levels in HepG2 Cells. | Nutrients | 2022 | 36145081 | PubTator, text mining | PubMed |
| Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas. | Int J Mol Sci | 2022 | 36142875 | PubTator, text mining | PubMed |
| Identification of AGR2 Gene-Specific Expression Patterns Associated with Epithelial-Mesenchymal Transition. | Int J Mol Sci | 2022 | 36142758 | PubTator, text mining | PubMed |
| Hypericum perforatum and Its Potential Antiplatelet Effect. | Healthcare (Basel) | 2022 | 36141386 | PubTator, text mining | PubMed |
| Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches. | Biomedicines | 2022 | 36140337 | PubTator, text mining | PubMed |
| An Oleocanthal-Enriched EVO Oil Extract Induces the ROS Production in Gastric Cancer Cells and Potentiates the Effect of Chemotherapy. | Antioxidants (Basel) | 2022 | 36139836 | PubTator, text mining | PubMed |
| MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway. | Cells | 2022 | 36139430 | PubTator, text mining | PubMed |
| Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape. | Front Pharmacol | 2022 | 36110544 | PubTator, text mining | PubMed |
| CCIVR facilitates comprehensive identification of cis-natural antisense transcripts with their structural characteristics and expression profiles. | Sci Rep | 2022 | 36109624 | PubTator, text mining | PubMed |
| The phenotype of the gut region is more stably retained than developmental stage in piglet intestinal organoids. | Front Cell Dev Biol | 2022 | 36105361 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2877/papers?page=17